What is ALD?
ALD, or Adrenoleukodystrophy, is a rare, inherited disorder that affects the nervous system and adrenal glands. It is caused by a genetic mutation that affects the production of a specific enzyme. This enzyme helps to break down a type of fat called very long-chain fatty acids. If the enzyme is not produced, these fatty acids build up in cells throughout the body and cause damage.
ALD is a progressive disorder, meaning that it gets worse over time. Symptoms can include weak muscle tone, poor coordination, difficulty walking, vision and hearing loss, seizures, and learning disabilities. In severe cases, ALD can lead to mental impairment and death.
Treatment in the UK
In the UK, treatment for ALD is available through the National Health Service (NHS). Treatment can include medications such as steroids, vitamin supplements, and anticonvulsants to help manage symptoms. In some cases, a bone marrow transplant may be recommended. This transplant can help to reduce the amount of fatty acids in the body and slow the progression of the disease.
Support and Resources
There are a number of organizations in the UK that offer support and resources for those affected by ALD. These include the ALD Life, which offers information and support to families, and the Adrenoleukodystrophy UK, which provides support to patients, their families, and healthcare professionals.
These organizations can help people to understand and manage the symptoms of ALD, as well as providing practical information and advice. They can also help to connect people with other families who are dealing with similar issues.